Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2)
Spicer, James F., Pinato, David James, Forster, Martin, Joshua, Anthony M., Korolewicz, James, Aboud, Karam, Morton, Cienne, Liu, Jia (Jenny), Cosman, Rasha, Main, Nicola Jane, Le Meur, Julia, Paull, Jeremy, Edmondson, Stephanie Ruth, Jones, Robert Hugh
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial
Liu, Jia (Jenny), Minchom, Anna Rachel, Greystoke, Alastair, Evans, T.R. Jeffry, Sarker, Debashis, Joshua, Anthony M., Morton, Cienne, Aktas, Burak Y, Cosman, Rasha, Chwialkowska, Dominika, Paull, Jeremy, Main, Nicola Jane, Jean-Francois, Bernadette Marie, Le Meur, Julia, Edmondson, Stephanie Ruth, Cook, Natalie
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Therapeutic dendrimer
Owen, David James, Edmondson, Stephanie Ruth, Fairley, Jacinth, Kelly, Brian Devlin, Main, Nicola Jane, Paull, Jeremy Robert Arthur
Year of Publication 27.08.2024
Get full text
Year of Publication 27.08.2024
Patent
THERAPEUTIC DENDRIMER
Owen, David James, Edmondson, Stephanie Ruth, Fairley, Jacinth, Kelly, Brian Devlin, Main, Nicola Jane, Paull, Jeremy Robert Arthur
Year of Publication 30.12.2021
Get full text
Year of Publication 30.12.2021
Patent